Effect of ANI on Intraoperative Opioid Consumption

November 4, 2021 updated by: Çağdaş Baytar, Zonguldak Bulent Ecevit University

Intraoperative Analgesia Management in Gynecological Surgery With Erector Spinae Block

The aim of the study is to compare the analgesic nociception index (ANI), which is used to determine the dose of analgesic agent needed in the intraoperative period, with the conventional method in patients with erector spinae block who underwent gynecological surgery under general anesthesia.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Anticipated)

35

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Kozlu
      • Zonguldak, Kozlu, Turkey, 67600
        • Recruiting
        • Zonguldak Bülent Ecevit University Medicine Faculty
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

female patients gynecological surgery under general anesthesia

Description

Inclusion Criteria:

  • ASA I-II-III risk group
  • Patients who underwent gynecological surgery under general anesthesia, who underwent erector spina block, and whose pain was followed by analgesia nociception index or conventional methods for intraoperative pain monitoring
  • Patients whose informed consent was read and consent was obtained from them and their guardians

Exclusion Criteria:

  • cardiac rhythm disorder
  • central-autonomic nervous system disease
  • neuropsychiatric disease
  • receiving opioid therapy
  • Use of drugs that will affect cardiac autonomic regulation
  • Known allergy to the drugs to be applied
  • Contraindicated for ESP block
  • Patients who do not agree to participate in the study will not be included in the study.
  • Patients who were administered drugs to stabilize the patient's hemodynamics during the operation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Group ANI
Group Control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
intraoperative opioid consumption
Time Frame: during the surgery
Effect of ANI monitoring on intraoperative opioid consumption
during the surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
emergence time
Time Frame: at the end of the surgery
time between last suture and extubation
at the end of the surgery
VAS pain scores
Time Frame: during her stay in the recovery unit
pain scores in the recovery unit
during her stay in the recovery unit
duration of stay in recovery room
Time Frame: at the end of the surgery
time between entering and exiting the recovery unit
at the end of the surgery
nausea and vomiting i
Time Frame: during her stay in the recovery unit
incidence of nausea and vomiting in recovery room
during her stay in the recovery unit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2021

Primary Completion (Anticipated)

February 28, 2023

Study Completion (Anticipated)

May 1, 2023

Study Registration Dates

First Submitted

October 22, 2021

First Submitted That Met QC Criteria

October 22, 2021

First Posted (Actual)

November 3, 2021

Study Record Updates

Last Update Posted (Actual)

November 11, 2021

Last Update Submitted That Met QC Criteria

November 4, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021/18-4

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe